A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis

Journal of Immunology

Volumn 180, Issue 4, 2008, Pages 2573-2580

  Ho, Johnson ^a   Kurtz, Courtney C ^a   Naganuma, Makoto ^a   Ernst, Peter B ^a   Cominelli, Fabio ^a   Rivera Nieves, Jesús ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; L SELECTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; ALPHA E INTEGRINS; ALPHA INTEGRIN; AUTACOID; HYALURONIC ACID; LEUKOCYTE ANTIGEN; LIGAND; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; ILEITIS; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE COUNT; MESENTERY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPLEEN; TRANSGENIC MOUSE; TRANSPLANTATION; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHRONIC DISEASE; HYALURONIC ACID; ILEITIS; INFLAMMATION MEDIATORS; INTEGRIN ALPHA CHAINS; LIGANDS; LYMPH NODES; LYMPHOCYTE COUNT; MESENTERY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPLEEN; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 42149164952     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.4.2573     Document Type: Article

References (49)

1. Izcue, A., J. L. Coombes, and F. Powrie. 2006. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212: 256-271.
2. + regulatory T cells. J. Immunol. 170: 3939-3943.
3. Powrie, F., S. Read, C. Mottet, H. Uhlig, and K. Maloy. 2003. Control of immune pathology by regulatory T cells. Novartis Found. Symp. 252: 92-98.
4. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
5. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
6. Podolsky, D. K. 1991. Inflammatory bowel disease. N. Engl. J. Med. 325: 928-937.
7. Kontoyiannis, D., M. Pasparakis, T. T. Pizarro, F. Cominelli, and G. Kollias. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398.
8. Sandborn, W. J., and S. R. Targan. 2002. Biologic therapy of inflammatory bowel disease. Gastroenterology 122: 1592-1608.
9. Kontoyiannis, D., G. Boulougouris, M. Manoloukos, M. Armaka, M. Apostolaki, T. Pizarro, A. Kotlyarov, I. Forster, R. Flavell, M. Gaestel, et al. 2002. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196: 1563-1574.
10. Burns, R. C., J. Rivera-Nieves, C. A. Moskaluk, S. Matsumoto, F. Cominelli, and K. Ley. 2001. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology 121: 1428-1436.
11. - regulatory T cells. Proc. Natl. Acad. Sci. USA 99: 13031-13036.
12. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
13. Nandi, A., P. Estess, and M. H. Siegelman. 2000. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J. Biol. Chem. 275: 14939-14948.
14. Siegelman, M. H., H. C. DeGrendele, and P. Estess. 1999. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukocyte Biol. 66: 315-321.
15. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180: 383-387.
16. Lesley, J., and R. Hyman. 1992. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur. J. Immunol. 22: 2719-2723.
17. Lesley, J., N. English, C. Charles, and R. Hyman. 2000. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding. Eur. J. Immunol. 30: 245-253.
18. + T cells. Science 248: 1227-1230.
19. Gunturi, A., R. E. Berg, and J. Forman. 2004. The role of CD94/NKG2 in innate and adaptive immunity. Immunol. Res. 30: 29-34.
20. Jiang, H., and L. Chess. 2006. Regulation of immune responses by T cells. N. Engl. J. Med. 354: 1166-1176.
21. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1D up-regulation. Immunity 16: 219-230.
22. Lu, L., M. B. Werneck, and H. Cantor. 2006. The immunoregulatory effects of Qa-1. Immunol. Rev. 212: 51-59.
23. Bai, Y., J. Liu, Y. Wang, S. Honig, L. Qin, P. Boros, and J. S. Bromberg. 2002. L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance. J. Immunol. 168: 1579-1589.
24. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169: 2461-2465.
25. + regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 101 (Suppl. 2): 14580-14585.
26. + regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204: 191-201.
27. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104: 3804-3812.
28. + regulatory T cells protects from lethal acute GVHD. Blood 105: 2220-2226.
29. + regulatory T cell migration requires L-selectin expression: L-selectin transcriptional regulation balances constitutive receptor turnover. J. Immunol. 178: 291-300.
30. ++bright phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age. J. Immunol. 170: 613-619.
31. Uchimura, K., and S. D. Rosen. 2006. Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol. 27: 559-565.
32. + regulatory T cells accumulate in dendritic cell aggregates of the colonic mucosa in murine transfer colitis. Am. J. Pathol. 168: 1898-1909.
33. + T cells during cure of colitis. J. Immunol. 177: 5852-5860.
34. Drayton, D. L., X. Ying, J. Lee, W. Lesslauer, and N. H. Ruddle. 2003. Ectopic LTαβ directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197: 1153-1163.
35. Iwata, M., A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S. Y. Song. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21: 527-538.
36. Campbell, D. J., and E. C. Butcher. 2002. Intestinal attraction: CCL25 functions in effector lymphocyte recruitment to the small intestine. J. Clin. Invest. 110: 1079-1081.
37. + recent thymic emigrants home to and efficiently repopulate the small intestine epithelium. Nat. Immunol. 7: 482-488.
38. + lymphocytes to the small-intestinal mucosa. J. Clin. Invest. 110: 1113-1121.
39. Mucida, D., Y. Park, G. Kim, O. Turovskaya, I. Scott, M. Kronenberg, and H. Cheroutre. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
40. + CTL. J. Immunol. 159: 3748-3756.
41. E (CD103)-deficient mice. J. Immunol. 162: 6641-6649.
42. Olson, T. S., G. Bamias, M. Naganuma, J. Rivera-Nieves, T. L. Burcin, W. Ross, M. A. Morris, T. T. Pizarro, P. B. Ernst, F. Cominelli, and K. Ley. 2004. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J. Clin. Invest. 114: 389-398.
43. Annacker, O., J. L. Coombes, V. Malmstrom, H. H. Uhlig, T. Bourne, B. Johansson-Lindbom, W. W. Agace, C. M. Parker, and F. Powrie. 2005. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202: 1051-1061.
44. Strober, W., B. Kelsall, I. Fuss, T. Marth, B. Ludviksson, R. Ehrhardt, and M. Neurath. 1997. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol. Today 18: 61-64.
45. + T cells. J. Immunol. 168: 2247-2254.
46. + T cells. J. Immunol. 177: 2775-2783.
47. Myers, L., M. Croft, B. S. Kwon, R. S. Mittler, and A. T. Vella. 2005. Peptidespecific CD8 T regulatory cells use IFN-γ to elaborate TGF-β-based suppression. J. Immunol. 174: 7625-7632.
48. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J. Immunol. 160: 5719-5728.
49. + regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J. Immunol. 174: 5814-5822.